Sysmex Corp 2025 IR
The report outlines Sysmex's integrated financial and non-financial performance for fiscal 2024, highlighting its long-term vision of enhancing the healthcare journey. The company achieved record-high net sales of 508.6 billion yen, driven by strong growth in its core hematology business and expansion in emerging markets like India. Key sustainability achievements include receiving validation from the Science Based Targets initiative (SBTi) and launching an industry-first horizontal recycling program for plastic reagent containers. Additionally, Sysmex expanded its direct sales operations in the hemostasis field in Europe and the United States and continued to deploy its robotic-assisted surgery system.
Company: Sysmex Corp
Sector: Health Care
Country: Japan
Year: 2025
Type: IR
Pages: 116
Sysmex Corp
Sysmex Report
The report outlines Sysmex's integrated financial and non-financial performance for fiscal 2024, highlighting its long-term vision of enhancing the healthcare journey. The company achieved record-high net sales of 508.6 billion yen, driven by strong growth in its core hematology business and expansion in emerging markets like India. Key sustainability achievements include receiving validation from the Science Based Targets initiative (SBTi) and launching an industry-first horizontal recycling program for plastic reagent containers. Additionally, Sysmex expanded its direct sales operations in the hemostasis field in Europe and the United States and continued to deploy its robotic-assisted surgery system.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 3:
Renewable Energy
Women in Management
Net Zero Target
Employees